1,038 results on '"Roccaro, Aldo M."'
Search Results
2. Diagnostics in Waldenström’s macroglobulinemia: a consensus statement of the European Consortium for Waldenström’s Macroglobulinemia
3. Targeting the immune microenvironment in Waldenström macroglobulinemia via halting the CD40/CD40-ligand axis
4. The role of clonal hematopoiesis as driver of therapy-related myeloid neoplasms after autologous stem cell transplantation
5. SARS-CoV-2 infection in dialysis and kidney transplant patients: immunological and serological response
6. Therapeutic activation of G protein-coupled estrogen receptor 1 in Waldenström Macroglobulinemia
7. Waking up exhausted BCMA-specific T cells in myeloma
8. Editor's Note: Eph-B2/Ephrin-B2 Interaction Plays a Major Role in the Adhesion and Proliferation of Waldenstrom's Macroglobulinemia
9. Editor's Note: Mechanisms of Activity of the TORC1 Inhibitor Everolimus in Waldenstrom Macroglobulinemia
10. Surfactant therapy for COVID-19 related ARDS: a retrospective case–control pilot study
11. Reduction in the rate and improvement in the prognosis of COVID-19 in haematological patients over time
12. Genomic Aberrations in Multiple Myeloma
13. Epigenetics in Multiple Myeloma
14. Vascular and Stromal Contributions to Tumor Bone-Homing: Focus on Multiple Myeloma
15. Molecular Pathways in Growth and Survival: Epigenomics
16. Starving multiple myeloma cells via CDK7 inhibition
17. Prognostic role of circulating exosomal miRNAs in multiple myeloma
18. Blocking IFNAR1 inhibits multiple myeloma-driven Treg expansion and immunosuppression
19. Inhibition of microRNA-138 enhances bone formation in multiple myeloma bone marrow niche
20. Data from ROBO1 Promotes Homing, Dissemination, and Survival of Multiple Myeloma within the Bone Marrow Microenvironment
21. Supplementary Methods from ROBO1 Promotes Homing, Dissemination, and Survival of Multiple Myeloma within the Bone Marrow Microenvironment
22. Supplementary Figures 1-15, Supplementary Table 1 from ROBO1 Promotes Homing, Dissemination, and Survival of Multiple Myeloma within the Bone Marrow Microenvironment
23. Supplementary Figure from Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma
24. Supplementary Table from Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma
25. Supplementary Data from Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma
26. Fig S6 from Platelets Enhance Multiple Myeloma Progression via IL-1β Upregulation
27. Data from FGF Trapping Inhibits Multiple Myeloma Growth through c-Myc Degradation–Induced Mitochondrial Oxidative Stress
28. Supplementary Table 1 from Platelets Enhance Multiple Myeloma Progression via IL-1β Upregulation
29. Supplementary Data from FGF Trapping Inhibits Multiple Myeloma Growth through c-Myc Degradation–Induced Mitochondrial Oxidative Stress
30. Supplementary Table Legend from Novel Targeting of Phospho-cMET Overcomes Drug Resistance and Induces Antitumor Activity in Multiple Myeloma
31. Supplementary Figure Legend from Mechanisms of Activity of the TORC1 Inhibitor Everolimus in Waldenstrom Macroglobulinemia
32. Supplementary Table from Novel Targeting of Phospho-cMET Overcomes Drug Resistance and Induces Antitumor Activity in Multiple Myeloma
33. Supplementary Figure 5 from Novel Targeting of Phospho-cMET Overcomes Drug Resistance and Induces Antitumor Activity in Multiple Myeloma
34. Supplementary Figure 1 from Novel Targeting of Phospho-cMET Overcomes Drug Resistance and Induces Antitumor Activity in Multiple Myeloma
35. Supplementary Figure Legends from Novel Targeting of Phospho-cMET Overcomes Drug Resistance and Induces Antitumor Activity in Multiple Myeloma
36. Supplementary Figure 2 from Novel Targeting of Phospho-cMET Overcomes Drug Resistance and Induces Antitumor Activity in Multiple Myeloma
37. Supplementary Methods from Novel Targeting of Phospho-cMET Overcomes Drug Resistance and Induces Antitumor Activity in Multiple Myeloma
38. Supplementary Figures S1-S3 from Carfilzomib-Dependent Selective Inhibition of the Chymotrypsin-like Activity of the Proteasome Leads to Antitumor Activity in Waldenstrom's Macroglobulinemia
39. Supplementary Data from Src Tyrosine Kinase Regulates Adhesion and Chemotaxis in Waldenstrom Macroglobulinemia
40. Supplementary Figure 3 from Novel Targeting of Phospho-cMET Overcomes Drug Resistance and Induces Antitumor Activity in Multiple Myeloma
41. Supplementary Figure 6 from Novel Targeting of Phospho-cMET Overcomes Drug Resistance and Induces Antitumor Activity in Multiple Myeloma
42. Supplementary Figure 1 from Mechanisms of Activity of the TORC1 Inhibitor Everolimus in Waldenstrom Macroglobulinemia
43. Supplementary Figure 4 from Novel Targeting of Phospho-cMET Overcomes Drug Resistance and Induces Antitumor Activity in Multiple Myeloma
44. Supplemental Legends from Cancer Cell Dissemination and Homing to the Bone Marrow in a Zebrafish Model
45. Data from Metabolic Signature Identifies Novel Targets for Drug Resistance in Multiple Myeloma
46. Supplemental Figures 1 - 5, Figure Legends and Methods from Metabolic Signature Identifies Novel Targets for Drug Resistance in Multiple Myeloma
47. Supplemental Figure S2 from Cancer Cell Dissemination and Homing to the Bone Marrow in a Zebrafish Model
48. Supplemental Table S1 from Cancer Cell Dissemination and Homing to the Bone Marrow in a Zebrafish Model
49. Diagnostics in Waldenström’s macroglobulinemia: a consensus statement of the European Consortium for Waldenström’s Macroglobulinemia
50. Targeting SDF-1 in multiple myeloma tumor microenvironment
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.